Fifty 410 vs Henry Meds

Both sell tirzepatide. Fifty 410 costs $133 a month and Henry Meds costs $449, a difference of $316 a month or about $3,792 a year. The desk reads it as follows.

Fifty 410 is prepaid blocks with no subscription. Henry Meds is sublingual and oral formats. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Fifty 410 advertises $133 and bills $133; Henry Meds advertises $399 and bills $449. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 2 of the 7 things we track, and behave the same on the other 5. The differences are what the price gap is actually buying.

What each puts on the record: Fifty 410

• Compounded tirzepatide starter protocol at $133/month, sold as a $399 three-month block.
• High-dose tirzepatide protocol at $183/month, sold as a $549 three-month block.
• No membership, no subscription and no recurring charges — you buy a block outright.
• Provider consultation and free 1-2 day shipping included in the price.
• States it is a telehealth platform that does not compound or distribute medication itself, and that preparations come from FDA-registered 503A pharmacies.
• Publishes unusually detailed information on 503A standards, USP 797 sterility and batch testing.
• No payment taken unless a provider approves you.

Where it wins: Genuinely no subscription — you buy a block and nothing recurs. Watch for: The $133 is the starter protocol. Moving to the high-dose protocol takes it to $183/month, and both are prepaid three-month commitments.

What each puts on the record: Henry Meds

• Injectable tirzepatide listed at $399 for the first month and $449/month recurring.
• Oral tirzepatide tablets listed at $299 first month, $349/month recurring.
• Compounded semaglutide injection around $297/month; sublingual around $249/month with a $179/month tier.
• Three-month oral tirzepatide supply $1,047, or $891 paid in full.
• Three-month oral semaglutide supply $747, or $537 paid in full.
• Advertising states pricing "starts at $179/month", which corresponds to the lowest sublingual tier.

Where it wins: No membership fee layered on top of medication. Watch for: The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month.

In each one’s favour

Fifty 410.

• Genuinely no subscription — you buy a block and nothing recurs.
• Among the lowest tirzepatide rates verified.

Henry Meds.

• No membership fee layered on top of medication.
• Real choice of sublingual, oral tablet and injection.

How they score

Fifty 410 scores higher overall at 4.2 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick Fifty 410 if cost is the binding constraint. Over a year the gap is about $3,792, which is real money for the same class of medication.
• Pick Henry Meds if what it does better matters to you — no membership fee layered on top of medication.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

On the board, Fifty 410 at $133 a month is the more defensible choice on arithmetic alone. Henry Meds earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Fifty 410 and Henry Meds.

How they sit against everyone else